Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vericel Corp VCEL

Healthcare Biotechnology
Vericel Corporation is a fully-integrated, commercial-stage biopharmaceutical company. The Company is a provider of advanced therapies for the sports medicine and severe burn care markets. It markets three products in the United States. MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous-cellularized scaffold product indicated for the repair of symptomatic... see more

Recent & Breaking News (NDAQ:VCEL)

Vericel to Present at the Ladenburg Thalmann Healthcare Conference

GlobeNewswire September 22, 2022

Vericel to Present at the Morgan Stanley Global Healthcare and H.C. Wainwright Global Investment Conferences

GlobeNewswire September 6, 2022

Vericel Reports Second Quarter 2022 Financial Results

GlobeNewswire August 3, 2022

MediWound Announces U.S. FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns

GlobeNewswire August 3, 2022

Vericel Announces Publication of Positive Results from Retrospective Study by the Burn and Reconstructive Centers of America (BRCA) of Patients with Large Posterior Trunk Burns Treated with Epicel

GlobeNewswire July 21, 2022

Vericel to Report Second-Quarter 2022 Financial Results on August 3, 2022

GlobeNewswire July 20, 2022

Vericel Reports First Quarter 2022 Financial Results

GlobeNewswire May 4, 2022

Vericel to Report First-Quarter 2022 Financial Results on May 4, 2022

GlobeNewswire April 20, 2022

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022

GlobeNewswire March 15, 2022

Vericel to Present at the Cowen 42nd Annual Health Care Conference on March 9, 2022

GlobeNewswire March 1, 2022

Vericel Announces Appointment of Jonathan Siegal as Principal Accounting Officer

GlobeNewswire February 24, 2022

Vericel Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Full-Year 2022 Financial Guidance

GlobeNewswire February 24, 2022

Vericel to Report Fourth-Quarter 2021 Financial Results on February 24, 2022

GlobeNewswire February 10, 2022

Vericel Announces Plans for a New State-of-the-Art Cell Therapy Manufacturing Facility to Support Long-Term Growth

GlobeNewswire February 2, 2022

Vericel to Present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022

GlobeNewswire January 4, 2022

Vericel to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on November 18th, 2021

GlobeNewswire November 11, 2021

Vericel Reports Third Quarter 2021 Financial Results

GlobeNewswire November 9, 2021

Vericel to Report Third-Quarter 2021 Financial Results on November 9, 2021

GlobeNewswire October 21, 2021

Vericel to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference on September 13th, 2021

GlobeNewswire September 8, 2021

Vericel Expands Executive Leadership Team and Announces Appointment of Patrick Fowler as Senior Vice President, Corporate Development and Strategy

GlobeNewswire September 7, 2021